David A Socks's Net Worth
$26.5 Million
Who is David A Socks?
David A Socks has an estimated net worth of $26.5 Million. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., HilleVax, Inc., and CADENCE PHARMACEUTICALS INC.
SEC CIK
David A Socks's CIK is 0001378847
Past Insider Trading and Trends
2023 was David A Socks's most active year for acquiring shares with 2 total transactions. David A Socks's most active month to acquire stocks was the month of April. 2021 was David A Socks's most active year for disposing of shares, totalling 41 transactions. David A Socks's most active month to dispose stocks was the month of January. 2023 saw David A Socks paying a total of $0.00 for 24,000 shares, this is the most they've acquired in one year. In 2021 David A Socks cashed out on 339,000 shares for a total of $13,165,559.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.055
President, CEO, Treas. & Sec.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9K |
—
|
—
| 9K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| -1.46% | -18.00K |
$32.58 | -$586,395.12 | 1.21M |
Scheduled
|
Oct 7 - Oct 8
| ||
Form 4
| -1.44% | -18.00K |
$32.63 | -$587,350.68 | 1.23M |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
| -1.42% | -18.00K |
$31.25 | -$562,538.16 | 1.25M |
Scheduled
|
Aug 16
| ||
Form 4
| -3.07% | -40.00K |
$34.05 | -$1,361,941.24 | 1.26M |
Scheduled
|
Jun 28 - Jun 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| -2.98% | -40.00K |
$32.64 | -$1,305,505.61 | 1.3M |
Scheduled
|
May 19 - May 20
| ||
Form 4
| -2.90% | -40.00K |
$36.55 | -$1,462,088.84 | 1.34M |
Scheduled
|
Apr 5 - Apr 6
| ||
Form 4
| -3.83% | -55.00K |
$47.58 | -$2,617,090.16 | 1.38M |
Scheduled
|
Mar 10 - Mar 12
| ||
Form 4
| -4.65% | -70.00K |
$46.49 | -$3,254,612.12 | 1.44M |
Scheduled
|
Feb 19 - Feb 23
| ||
Form 4
| -2.54% | -40.00K |
$35.70 | -$1,428,037.94 | 1.53M |
Scheduled
|
Jan 11 - Jan 12
| ||
Form 4
| -4.82% | -79.66K |
$43.42 | -$3,458,895.77 | 1.57M |
Scheduled
|
Dec 16 - Dec 17
| ||
Form 4
| -0.91% | -30.34K |
$40.53 | -$1,253,198.14 | 3.32M |
Scheduled
|
Nov 9 - Nov 11
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HilleVax, Inc. (HLVX) Snapshot price: $14.995
CFO & Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CADENCE PHARMACEUTICALS INC No price found
VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||